Claim/exemption information - Registry number 3691831

Case number
2024-130783
Claimant name
Buckman Laboratories of Canada, Ltd.
Product identifier
BUBREAK 4253
Claim type
Original
Date of filing
Non-compliance(s) identified on SDS and/or label
Yes, Order issued
SDS and/or label compliance review decision date
Claim/exemption status
Cancelled
Date of claim/exemption status

Additional information

Date of the order
Order status
Unresolved

List of suggested corrective measures

  • Disclose an adequate product odour.

  • Disclose ingestion as a likely route of exposure.

  • Disclose the HMIRA registry number and date of decision granting the exemption.

  • Disclose the additional hazard classifications for the product (see appendix 1).

  • Disclose the correct and complete LD50 values (see appendix 4).

  • Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 2).

  • Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 2).

  • Disclose the product oral acute toxicity estimate (ATE) of 160,000 mg/kg (10% unknown), and product dermal ATE of 250,000 mg/kg (10% unknown), respectively.

  • Disclose the relevant precautions for safe handling (see appendix 3).

  • Disclose the restrictions on use.

  • Disclose the solubility.

Date modified: